Get Certified as a Psychedelic-Assisted Therapy Provider (PATP)*
*Optional in-person ketamine experiential retreat
July 2021 – May 2022
Accelerate your therapy practice with the power of psychedelic medicine. Psychotherapy is undergoing another revolution: the fifth-wave of psychotherapy has arrived. With the aid of psychedelic medicines, many clients have an opportunity to break through long-standing trauma and mood issues in a matter of sessions rather than struggling for years. Deepen your skillset and learn how to harness the incredible power of psychedelic therapy. Join the revolution now.
Who should join the Psychedelic-Assisted Therapy Training?
This training is designed for therapists, physicians, nurses and other allied mental healthcare professionals who want comprehensive training in psychedelic-assisted therapy, in order to utilize ketamine as a psychedelic medicine and ready themselves for the anticipated approvals of MDMA and psilocybin.
This program is definitely for you if:
This online year-long course, taught by more than 30 experts in providing psychedelic-assisted therapy and research, will teach providers the protocols of evidence-based psychedelic-assisted therapy treatment for PTSD, depression, anxiety, and more. It will also go into the details of psychedelic sciences, therapeutic processes unique to psychedelic therapy, preparation, dosing, integration, clinic models, and how psychedelics work in combination with other types of therapies.
This 150 hour program was designed from the ground up to be taken online, allowing a busy therapist to take it without traveling.
Participants who attend the experiential live portion of the training will be eligible to become a Certified Psychedelic Assisted Therapy Practitioner and receive a certificate of completion. If you do not choose the in-person experiential option you may still earn a certificate of completion upon the successful completion of program requirements, but you will not be eligible for the certification.
The hard truth about mental illness
The field of therapy has achieved many important advances over the last few decades. But despite these advances we are unfortunately not making a significant dent in the massive mental health crisis on this planet.
Depression is now the leading cause of disability worldwide and is predicted by 2030 to be the leading cause of the global burden of disease by the World Health Organization.
90% of people experience trauma in their lifetime, according to a 2013 study. About 8 million people have PTSD in the U.S. in any given year. For our veterans, the PTSD and suicide rates are much higher. It’s hard to accept the statistic reported by the Veterans Administration that 22 veterans die by suicide each day.
1 in 5
adults experience some form of mental illness each year, and of these patients many have symptoms so severe their illness dramatically reduces their quality of life, limiting what they can and cannot do.
“Recent data suggest that ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades. First and most important, several studies demonstrate that ketamine reduces depression within six hours, with effects that are equal to or greater than the effects of six weeks of treatment with other antidepressant medications. Second, ketamine’s effects have been noted in people with treatment-resistant depression. This promises a new option for people with some of the most disabling and chronic forms of depression, whether classified as major depressive disorder or bipolar depression. Third, it appears that one of the earliest effects of the drug is a profound reduction in suicidal thoughts.” (October 1, 2014 NIMH Director’s Blog)
Tom Insel MD, former Provost of Harvard University, American neuroscientist and former Director of the National Institute of Mental Health (NIMH) from 2002 until November 2015
The Integrative Psychiatry Institute program is unlike any other psychedelic training offered. Not only will you learn from the world’s leading experts in psychedelic therapy, you also will learn an integrative approach to mental healthcare that is long overdue.
Imagine not only offering clients a breakthrough with psychedelics, but also having an entirely new framework for mental health and the knowledge to properly set up clients for a path forward.
Watch the video to hear from a fellowship program participant about what it’s like to learn at the Integrative Psychiatry Institute and how we are different.
How we are different from other psychedelic therapy trainings
Gain proficiency in a new therapy modality online in a year long format
Engage with over 30 faculty experts
Learn how to get involved in ketamine-assisted therapy now
Get prepared for MDMA therapy and Psilocybin therapy
90% live virtual learning with tons of faculty and teaching assistant contact
Community forum with faculty involvement for answers to your questions
In-person ketamine experiential retreat option
Limited spots available
You will be supported throughout your studies by a faculty of world-renowned leaders in psychedelic-assisted therapy and research. The faculty at the Integrative Psychiatry Institute is composed of the top-tier experts in their respective fields, teaching you the research, science and clinical skill sets needed for the use of ketamine, MDMA and psilocybin therapies.
For more than thirty years, Michael Pollan has been writing books and articles about the places where the human and natural worlds intersect: on our plates, in our farms and gardens, and in our minds. Pollan is the author of eight books, six of which have been New York Times bestsellers; three of them (including his latest, How to Change Your Mind) were immediate #1 New York Times bestsellers…
Robin Lester Carhart-Harris
Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression…
Rick Doblin, PhD
Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana…
Gabor Maté, MD
Dr. Mate is a bestselling author of four books published in twenty-five languages, and is an internationally renowned speaker on addiction, trauma, and childhood development. For his groundbreaking work he has been awarded the Order of Canada…
Annie Mithoefer, BSN
Annie Mithoefer, BSN, is a Registered Nurse living in Asheville, NC. She was co-investigator on two of the MAPS-sponsored Phase 2 clinical trials for individuals with PTSD and a pilot study treating couples combining MDMA-assisted psychotherapy with Cognitive Behavioral Conjoint Therapy for PTSD…
Michael Mithoefer, MD
Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC, with a research office in Charleston, SC. In 2000 he began collaborating with MAPS on the first US Phase 2 clinical trial of MDMA-assisted Psychotherapy. He and his wife Annie have since conducted two of the six MAPS-sponsored Phase II clinical trials testing…
Resmaa Menakem, MSW, SEP
Resmaa Menakem, New York Times bestselling author of My Grandmother’s Hands: Racialized Trauma and the Pathway to Mending Our Hearts and Bodies, is a visionary Justice Leadership coach, organizational strategist and master trainer. Resmaa is a leading voice in today’s conversation on racialized trauma. Resmaa created Cultural Somatics, which utilizes the body and resilience as mechanisms for growth…
Joan Borysenko, PhD
Joan Borysenko, Ph.D., is a distinguished pioneer in integrative medicine and is a world-renowned expert in the mind/body connection. Her work has been foundational in an international healthcare revolution that recognizes the role of meaning and spirituality in health and healing…
Allyson Grey, MFA
Allyson Grey is a painter and social sculptor. With an MFA from Tufts University, Grey has long been an art educator, arts organizer and muse to artists worldwide. Since art school in 1975, Allyson has collaborated and shared a studio with the artist, Alex Grey. The Grey’s co-founded the Chapel of Sacred Mirrors, (CoSM; cosm.org), a spiritual retreat center for artists outside of New York City…
Alex Grey’s legendary visionary art has been featured in venues as diverse as the album art of TOOL, SCI, the Beastie Boys and Nirvana, Time and Newsweek magazines, the Discovery Channel, rave flyers and sheets of blotter acid. Exhibited worldwide, Alex’s art has been honored with solo exhibitions at Feature Inc., Tibet House, Stux Gallery, P.S. 1, The NYC Outsider Art Fair, The New Museum in NYC, the Grand Palais in Paris, the Sao Paulo Biennial in Brazil…
Francoise Bourzat, MA
Françoise Bourzat, MA, has been bridging the divide between western psychology and indigenous wisdom in collaboration with healers in Huaulta de Jiminez, Mexico for the past 30 years. She is a founder of the Center for Consciousness Medicine, which trains people to become guides in a holistic method of psychedelic assisted therapy…
Pat Ogden, PhD
Pat Ogden, PhD, is a psychotherapist, renowned innovator in somatic psychology, and leading expert in working through the body to resolve trauma. She developed Sensorimotor Psychotherapy, a body-oriented approach to help patients process traumatic memories and manage threat responses…
William Richards, PhD
Bill A. Richards, PhD, a psychologist in the Center for Psychedelic and Consciousness Research in Baltimore, has been implementing research studies with psilocybin within the psychiatry department of the Johns Hopkins School of Medicine since 1999. He also is associated with the Program in Psychedelic Therapies and…
The faculty at the Integrative Psychiatry Institute is composed of the top-tier experts in their respective fields, teaching you the latest breakthroughs in psychiatric care.
Kekuni Minton, PhD
Kekuni Minton, PhD, is a founding trainer of Sensorimotor Psychotherapy Institute (SPI) and co-author of Trauma and the Body: A Sensorimotor Approach to Psychotherapy (2009)…
Arielle Schwartz, PhD
Arielle Schwartz, PhD is a licensed clinical psychologist, EMDR Therapy consultant, and certified yoga instructor with a private practice in Boulder, Colorado…
Megan Oxley, MD
Megan Oxley, MD is the founder and medical director of Michigan Progressive Health. A Board Certified Emergency Medicine physician, Dr. Oxley graduated from prestigious Wayne State University in 2009…
Sandhya Prashad, MD
Sandhya Prashad, MD is a board certified psychiatrist specializing in interventional modalities for treatment resistant disorders with a particular interest and expertise in ketamine therapy. She completed both medical school and psychiatry residency at Baylor College of Medicine…
Amy Emerson, BA
Amy Emerson, BA, is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization…
Berra Yazar-Klosinski, PhD
Berra Yazar-Klosinski, PhD, is a Deputy Director of the 501(c)(3) non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). She also serves as the Chief Scientific Officer (CSO) for the MAPS Public Benefit Corporation (MAPS PBC)…
Charles Raison, MD
Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Department of Psychiatry, University of Madison, WI. He is the co-author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017…
Joseph McCowan, PsyD
Joseph McCowan, PsyD, is a licensed clinical psychologist and psychotherapist, currently working in Los Angeles as a co-therapist in the MAPS sponsored phase 3 clinical trials of MDMA-Assisted Psychotherapy for PTSD…
Devon Christie, MD
Devon Christie, MD, is a family physician and certified Functional Medicine provider with a focused practice in chronic pain management. Devon is also a Registered Therapeutic Counsellor and certified Relational Somatic Therapist…
Ian Wickramasekera, PsyD
Ian Wickramasekera, PsyD, a clinical psychologist and have been a teacher of transpersonal psychology for over 20 years. He taught counseling related courses at Naropa University since 2015 and previously taught at Saybrook University…
Lisa Harding, MD
Lisa Harding, MD, is a graduate of the Yale School of Medicine. She finished her training as the Chief Resident of Intervention Psychiatric Services at Yale Psychiatric Hospital. She is now a Clinical Instructor in the Department of Psychiatry at the Yale School of Medicine…
Shannon Carlin, MA, LMFT
Shannon Carlin, MA, LMFT, is the Director and Head of Training and Supervision at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS)…
Terence Ching, PhD
Terence Ching, PhD, is a postdoctoral associate at the Yale OCD Research Clinic. Terence received his PhD and Master’s in clinical psychology from the University of Connecticut. Prior to moving to the United States, Terence received his Bachelor’s and Master’s degrees in psychology at the National University of Singapore…
Brooke Balliett, LMFT
Brooke Balliett, LMFT, is a licensed marriage and family therapist in Los Angeles, CA. Brooke has a passion for treating psychological, spiritual, emotional and relationship challenges through the development of self-awareness, emotional intelligence and recognition of the healing power we each inherently hold inside of us…
Beatriz Caiuby Labate, PhD
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist based in San Francisco. She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, religion and social justice…
The psychedelic therapy training is led by top-tier experts in their respective fields, teaching you the latest breakthroughs in psychedelic-assisted therapy.
Will Van Derveer, MD
Will Van Derveer, MD, Co-Founder of the Integrative Psychiatry Institute and Integrative Psychiatry Centers, conducted MDMA clinical research and provided MDMA-assisted psychotherapy with MAPS for several years. He has been providing and teaching others how to provide ketamine-assisted therapy for several years. In the 2021 publication of the “Handbook of Medical Hallucinogens”…
Keith Kurlander, MA, LPC
Keith Kurlander, MA, LPC is the Co-founder of the Integrative Psychiatry Institute and the Integrative Psychiatry Centers. He has practiced integrative psychotherapy for over a decade. After years of treating highly complex patients, as well as a personal journey of overcoming complex mood-related issues, he turned toward integrative psychiatric practices as a key component to understanding the healing process…
Sara Gael, MA, LPCC
Sara is a transpersonal psychedelic therapist and teacher. She has worked as a therapist for the Phase 2 and 3 clinical trials for MDMA-assisted therapy for PTSD sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). Sara served as the Director of the MAPS Harm Reduction department from 2016-2020 and continues to develop curriculum and training…
Kelly McCarter, MBA has nearly 10 years of finance, operations and strategy experience across companies ranging from large cap to start-ups, both private sector and publicly traded, and across a wide range of industries. Kelly’s personal passion for an intuition-led, wellness-focused lifestyle combined with her business experience…
Student Success Coordinator
A lifetime ago, Erin received a BA in psychology and a double minor in holistic health & wellness, and nutrition. She is a certified health coach, yoga, breath, and meditation instructor, and a self-proclaimed food nerd. A plant-fueled human, she’s a firm believer in seasonal, organic, real food. This naturally makes her an advocate against cruelty and abuse of any kind to animals, people, and nature…
Student Success Coordinator
Jaime received his Master of Arts in Counseling from Regis University and is a Licensed Professional Counselor in the state of Colorado. Originally Born in Puerto Rico, and raised in a military family, Jaime has spent time in Europe, Central America, and many states in the US. He brings a unique blend of interpersonal, analytic and technical skills to his healing work and also provides services in Spanish…
Earn Continuing Education Credits (CE/CEU/CME)
We are actively seeking a CE/CEU provider and plan on 100 hours of the program counting toward CE/CEU for therapists. In many states that can cover two years worth of continuing education requirements. We will update this section upon approval.
We are also seeking approval and plan on 50 hours of the program to count toward continuing medical education credits. We will update this section upon approval.
What You’ll Get
The IPI Psychedelic-Assisted Therapy Training has been designed to take advantage of recent advances in online education, with 150 hours of learning, allowing participants to get involved with psychedelic therapy and to sharpen your skills and get certified if you are already practicing.
Every session is recorded in your online library, and readily available, in case your schedule does not permit you to attend a certain session online. In addition, you will have access to your online library for an entire year after the program ends
Online Pre-Training Modules
This 15 hour series, available to you before the start of the actual program, is designed to introduce the basics so you can get started learning today.
Virtual Intensive I
Our training begins with the Live Virtual Intensive July 16th-18th, 2021 consisting of 20 hours of highly-engaging talks by expert faculty where you will learn the fundamentals of psychedelic-assisted therapy while building community.
10 months of weekly 60 minute online lectures and panel discussions to help you become an expert in psychedelic-assisted therapy.
Large Group Seminars
10 Months of weekly 60 minute online groups in breakout rooms where you will practice and discuss different techniques of psychedelic-assisted therapy.
Small Group Sessions
Two zoom calls per month in your small group assignments discussing cases, homework and other relevant topics.
Community discussion and interaction with teaching assistants and faculty will occur through an innovative private online portal throughout the program, to ensure you have the support to maximize your learning experience
Virtual Intensive II
Our training wraps up with Live Virtual Intensive May 6th-8th, 2022, with advanced topics and innovative specialized methods to ensure participants are confident in their new knowledge, and have the expertise to apply it correctly in their practices.
In-person Experiential Training (Optional)
Attend a 3-day intensive in Boulder, Colorado with your training cohort where you will have the opportunity to practice ketamine-assisted therapy with participants on ketamine. You will also have the opportunity to experience receiving a ketamine-assisted therapy session as a training method. This is required to receive the certification title.
In order to create a program that leads to a certification, the program focuses on five modules to gain expertise as a psychedelic-therapy provider.
Research and Science
- Explore the current psychotherapy research protocols
- Grasp the chemistry and pharmacology
- Learn about proposed mechanisms of action
- Get up to date on MDMA, Psilocybin, and Ketamine research
- Find out about the history of psychedelic research
- Understanding dosing protocols
- Medical safety issues to know about
- Regulatory Compliance topics
- Use techniques specific to psychedelic therapy
- How to work with the Inner Healing Intelligence
- Applying attachment theory in therapeutic process
- Implementing somatic therapy techniques, parts work, & IFS
- How to be with non-ordinary states of consciousness
- Understanding Trauma Neuroscience
- Providing adequate preparation and integration
- Essentials of the Set and Setting
- Navigating the safe uses of therapeutic touch
Integrative Treatment Planning
- How to achieve values-based behavior change
- Addressing an expanded spectrum of root causes
- What to know about medications and supplements
- How to maintain progress with lifestyle changes
- Mind-body practices to support integration
- Basic nutritional recommendations for optimal mental health
- Psychedelics inside an integrative model of mental health
- Essentials of harm reduction
- Ethics in psychedelic assisted therapy
- Providing culturally competent care
- Diversity, Equity, Inclusion in psychedelic medicine
- Addressing access to care issues
- Professional Liability
- Policy, Advocacy, and Collaboration
- Learn about clinic models and individual psychotherapy
- Therapist Self-Regulation
- Transference and Countertransference
- Protecting boundaries in psychedelic sessions
- Practicing therapist self-care
- Exploring holotropic breathwork
- Embracing ongoing personal growth work
- Understanding the importance of mystical & spiritual
- Using meditation & mindfulness for self exploration
- Developing therapist self-growth practices
Limited spots available
Diversity, Equity, and Inclusion
At IPI we take the position that different perspectives and backgrounds are necessary for a vibrant community to thrive. In the field of psychedelic-assisted therapy, there are not enough providers who identify as members of groups who have been oppressed or marginalized. Particularly poignant is the reality that therapists who do not identify as members of the BIPOC and LGBTQIA+ communities struggle with providing care that is both culturally competent and sensitive to the unique challenges of oppression and marginalization. We are committed to a diverse faculty, equity among the learners and education that creates cultural competency.
BIPOC & LGBTQIA+ Scholarships
Our Diversity Outreach Program is on a mission to increase diversity among the psychedelic therapy community, and to support inclusion to those who identify as Black, Indigenous, or People of Color (BIPOC) and Lesbian, Gay, Bisexual, Transgender, Queer, Questioning, Intersex, and Asexual (LGBTQIA+). In support of our commitment to inclusivity and diversity, we will be awarding scholarships at a 50% discount to qualified applicants. Please ask about details on your discovery call in order to apply. Scholarship will be awarded by May 1st, 2021.
We are committed to support military veterans to gain access to training in psychedelic-assisted therapy. If this is you, please ask about our 30% discount for veterans on your discovery call.
In-person Ketamine-Assisted Psychotherapy Retreat in Boulder, Colorado
Friday, Saturday, Sunday
A unique feature of this program is the opportunity to gather in person with a group of fellow learners for a 3-day (Friday, Saturday, Sunday) retreat in Boulder, CO. Experiential learning is considered by many psychedelic therapy pioneers to be essential to gaining proficiency in psychedelic therapy. Retreat with colleagues to learn about psychedelic therapy is also a great opportunity to build community.
During this retreat, you will provide ketamine-assisted psychotherapy and will also be given the option to participate as a client. Participating as a client is not required to attend the retreat.
**Attending this experience in person is a requirement to meet the criteria to sit for the “Certified Psychedelic Assisted Therapy Provider” certification examination. Undergoing a ketamine therapy experience at this training is not required and requires a ketamine medical screening. If you do not choose this option you will still receive a certificate of completion upon the successful completion of program requirements.
How Can I Use This Psychedelic Training?
The IPI certification is designed for qualified professionals who already have a significant foundation of relevant training and experience providing mental healthcare. Certification and certificates of completion will be awarded upon successful completion of the program and demonstrating core competencies.
The only psychedelic medicine currently available to provide in a medical setting in the United States is ketamine. In this program you will learn about how to get involved, ethically and safely, with ketamine-assisted therapy. MDMA- and psilocybin-assisted therapy are currently in phase 3 FDA trials, and [for now] remain on US DEA schedule 1, making them illegal to use outside an approved research setting. As a training institute, we support following the outcomes of validated research, and, upholding the laws of the country in which you reside.
Who Can Apply:
You must have an advanced degree in either medicine or mental health in order to apply. If you are an early career mental health or medical professional, we encourage you to apply so we can discuss your situation and evaluate whether this program fits for your level of experience.
Professional Clinical Counselors (LPC)
Early Registration Tuition Available Until July 1st, 2021
Add-On Optional In-Person Ketamine-Assisted Psychotherapy Experience and Certification Fees (does not include travel expenses)
Limited spots available
Our commitment to furthering your education
The knowledge, experience, and confidence you will gain from attending the IPI Psychedelic Assisted Therapy Training is unparalleled.
No other program provides a learning experience like this, from the quality of training to the world-class faculty ready for your every question.
The IPI Psychedelic Therapy Training is a year-long online course that will not only help you feel confident providing ketamine, but will also bring your knowledge base up to date on the latest evidence.
Make an investment in yourself and your education. Take your practice to a new level of patient care.
And if you’re not happy with the program, you can get a full refund within the first 30 days after the date that you pay and register. Simply reach out to our team, let us know what we could have done better, and your refund will be on its way.
Have more questions? email@example.com
Frequently Asked Questions
Our online lectures will be scheduled in a regular time-slot during business hours so you can plan your schedule accordingly. However, if you cannot attend any of these lectures you will always have access to recordings of them in your online library.
There will be time during the large group seminars for feedback from teaching assistants, as well as during the live experience if you attend. In addition there is time for Q+A during every live lecture, as well as a community forum. You will also be assigned to a small group mentorship video call that meets for an hour twice a month with rotating faculty, where you can review case studies and ask further questions. The mentorship calls will also be added to your online library.
Your course materials will be available for a full year following the completion of the program.
Currently, no national board certification exists for psychedelic-assisted therapy. If you choose to partake in the optional live retreat, you will become eligible for certification and will be awarded it upon successful completion of the program and demonstrating core competencies. If you choose not to participate, you will still receive a certificate of completion upon successful completion of the program and demonstrating core competencies.
You are expected to attend both online conferences. We will be doing important group exercises, in addition to other community building activities. Please contact us with any extenuating circumstances.
Immediately! As soon as you register, you will have received an account on the IPI website. The pre-training material will be uploaded over the course of March.
Recordings are video, audio and transcripts. Generally, a slide deck is also used by the presenter.